Symposium - European Medical Journal

Continue

Symposiums

Oncology
3 Mins
19 Feb 2021

Final Results from the ClarIDHy Phase III Study of Ivosidenib Versus Placebo in Patients with Previously Treated Cholangiocarcinoma and an Isocitrate Dehydrogenase 1 (IDH1) Mutation

Cholangiocarcinoma (CCA) is a rare cancer for which there are limited effective therapies.1,2 Mutations in the isocitrate dehydrogenase 1 gene (IDH1)…
Dermatology
9 Mins
18 Feb 2021

Biological and Clinical Impacts of Ultraviolet-A on the Skin: New Insights

Terrestrial solar UVR consists of UVA (320–400 nm) and UVB (280–320 nm; typically around 295–320nm because of attenuation by the ozone…
Gastroenterology
10 Mins
11 Feb 2021

TDM and T2T – Perfect Partners?

This webinar opened with an introduction to therapeutic drug monitoring (TDM) in inflammatory bowel disease (IBD) by Dr Baert, as well as an explanation…
Dermatology
11 Mins
10 Feb 2021

Long-term Efficacy and Safety of Tildrakizumab: 5-year Results from the reSURFACE 1 and 2 Phase III Trials in Patients with Moderate-to-severe Plaque Psoriasis

Psoriasis, a chronic systemic inflammatory disease with skin manifestations, can be an impediment to daily life. Accordingly…
Cardiology
4 Mins
29 Jan 2021

Mavacamten Positively Impacts Underlying Hypertrophic Cardiomyopathy Mechanisms as Well as Cardiac Structure and Function: Findings from the EXPLORER-HCM Study

Obstructive hypertrophic cardiomyopathy (HCM) is a progressive myocardial disorder characterised by dynamic left ventricular outflow tract (LVOT)…
EMJ Oncology 9 [Supplement 1] 2021 feature image
Oncology
10 Mins
12 Jan 2021

Expanding Possibilities in EGFR-Mutated Advanced NSCLC: Interviews with Four Key Opinion Leaders

Worldwide, there were approximately 2.10 million patients diagnosed with, and 1.77 million deaths caused by, lung cancer in 2018. Approximately…
EMJ Cardiology 8 [Supplement 4] 2020 Feature Image
Cardiology
8 Mins
22 Dec 2020

Long-Term Benefits of a Holistic Approach on Dyslipidaemia Management

Prof Banach explained that current lipid-lowering therapy (LLT) with statins, ezetimibe, and proprotein convertase subtilisin/kexin Type 9 inhibitors…
Allergy & Immunology
11 Mins
22 Dec 2020

Human Milk Oligosaccharides: New Developments in the Management of Cow’s Milk Protein Allergy

This symposium, which was part of the industry programme at Food Allergy and Anaphylaxis Meeting and the European Consortium on Application…